Cleerly ISCHEMIA vs A View LCS

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Cleerly
VS
by Coreline Soft

AI Verdict

Tool A is designed for detailed, non-invasive assessment of coronary artery ischemia and plaque characteristics from CCTA scans. In contrast, Tool B offers a broader thoracic analysis, primarily focusing on lung cancer screening and emphysema quantification, while also providing coronary artery calcification scoring from low-dose CT scans. Therefore, while both contribute to cardiac health insights, their primary applications and the specific cardiac conditions they target differ significantly.

Choose Cleerly ISCHEMIA if…

Choose Cleerly ISCHEMIA if your primary goal is to non-invasively assess the likelihood of coronary artery ischemia at a vessel level using CCTA scans. This tool is ideal for physicians seeking detailed coronary plaque characterization, stenosis severity assessment, and non-invasive fractional flow reserve (FFR) estimation to guide personalized treatment plans for heart disease.

View Cleerly ISCHEMIA →

Choose A View LCS if…

Choose AVIEW LCS if you require a comprehensive AI-powered platform for thoracic CT analysis, particularly for lung cancer screening programs. This tool is best suited for scenarios where a single low-dose CT scan needs to be leveraged for automated lung nodule detection, emphysema quantification, and coronary artery calcium scoring, providing a holistic view of thoracic health.

View A View LCS →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cleerly ISCHEMIA A View LCS
Pricing Contact for details Unknown
Deployment Web-based platform; data transfer via Cleerly Proxy (VPN or virtual appliance) Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker). It can also be integrated into standard reading environments (PACS), RIS (Radiological Information System), or used as a standalone third-party application or web-based application.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

A View LCS

AVIEW LCS emphasizes streamlined workflows with claims of up to 79% faster reading times and out-of-the-box installation requiring minimal IT support, directly addressing user efficiency and ease of deployment. While Cleerly ISCHEMIA offers interactive web-based reports and API integration, AVIEW LCS's focus on reducing radiologist workload and its UI/UX upgrades in version 2.0 give it a slight edge in overall usability.

Clinical Value

Cleerly ISCHEMIA

Cleerly ISCHEMIA provides advanced cardiac analysis, including non-invasive fractional flow reserve (FFR) estimation and detailed coronary plaque characterization, which offers deeper insights into heart disease beyond traditional anatomical assessment. Its clinical utility is strongly supported by multiple trials (CREDENCE, PACIFIC) demonstrating high diagnostic accuracy and prognostic value for major adverse cardiac events, and it has a dedicated Category I CPT code for reimbursement.

Pricing & Value

Cleerly ISCHEMIA

While both tools require direct contact for pricing, Cleerly ISCHEMIA's eligibility for the Category I CPTu00ae code 75580 for non-invasive FFR estimation provides a clear and standardized pathway for reimbursement. This directly enhances its financial value proposition for healthcare providers by facilitating billing and coverage. AVIEW LCS mentions time savings and ROI, but lacks a comparable direct billing mechanism in the provided information.

Enterprise Readiness

A View LCS

AVIEW LCS offers superior enterprise readiness due to its highly flexible deployment options, including cloud, hybrid, local hardware, and virtualized solutions, catering to diverse IT infrastructures. It explicitly states compatibility with 'all major PACS' and 'out-of-the-box installation with minimal IT support,' indicating robust integration capabilities. Furthermore, Coreline Soft holds additional certifications like GDPR and ISO 27001, demonstrating a broader commitment to enterprise-level security and data governance.

Innovation

Cleerly ISCHEMIA

Cleerly ISCHEMIA demonstrates a higher degree of innovation by offering non-invasive fractional flow reserve (FFR) estimation and comprehensive coronary plaque characterization from CCTA scans. This moves beyond anatomical assessment to provide functional insights and detailed disease phenotyping, which is a significant advancement in non-invasive cardiac diagnostics.

Support & Docs

Tie

Both companies provide clear contact channels for customer support, including email and phone. Cleerly specifies operating hours and prioritizes after-hours needs, indicating a structured support system. Coreline Soft offers multiple regional contacts and a dedicated customer service email. Without specific details on service level agreements, documentation comprehensiveness, or user satisfaction metrics, it is not possible to definitively declare a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cleerly ISCHEMIA A View LCS
Name Cleerly ISCHEMIA A View LCS
Primary Focus Analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease. AI-powered medical imaging platform for comprehensive thoracic CT analysis, specializing in lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan.
Company Cleerly Coreline Soft Co.
Target Specialties Cardiology, Radiology Cardiology, Pulmonology, Radiology
Key Cardiac Analysis Features AI-enabled CCTA analysis, Non-invasive fractional flow reserve (FFR) estimation, Vessel-level ischemia likelihood determination, Coronary plaque characterization (volume, type, location), Stenosis severity assessment, 3D digital models of coronary arteries. Coronary Artery Calcium (CAC) scoring (Agatston, volume, mass), Segmentation of major coronary arteries.
Key Lung Analysis Features Not specified Automated lung nodule detection and classification, Nodule volume quantification and measurement (3D), Lung-RADS scoring and reporting, Emphysema analysis and quantification (LAA).
Reporting Capabilities Comprehensive interactive web-based reports, Integration with PowerScribe via API. Automated comprehensive report generation (PDF, DICOM PDF, SR).

Videos

Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and A View LCS.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cleerly ISCHEMIA focuses on non-invasive fractional flow reserve (FFR) estimation, vessel-level ischemia likelihood, and coronary plaque characterization from CCTA scans. A View LCS specializes in coronary artery calcium (CAC) scoring (Agatston, volume, mass) and segmentation of major coronary arteries from low-dose CT scans.
A View LCS provides comprehensive thoracic CT analysis, including automated lung nodule detection and classification, nodule volume quantification, Lung-RADS scoring, and emphysema analysis. Cleerly ISCHEMIA is specifically designed for detailed coronary artery analysis and ischemia detection.
Cleerly ISCHEMIA determines the likelihood of coronary artery ischemia at a vessel level, assesses stenosis severity, and characterizes plaque volume, type, and location. A View LCS provides coronary artery calcium (CAC) scoring, which is a key indicator for cardiovascular risk assessment.
Cleerly ISCHEMIA is specifically designed to analyze CCTA (Coronary CT Angiography) scans to provide detailed insights into coronary arteries. A View LCS performs comprehensive thoracic CT analysis, specializing in findings from a single low-dose CT scan, which can include lung and cardiac assessments.
Cleerly ISCHEMIA provides comprehensive interactive web-based reports and offers integration with PowerScribe via API. A View LCS generates automated comprehensive reports in formats like PDF, DICOM PDF, and SR, and also features CT kernel conversion AI technology.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.